Loading company…
Zhigong Biomedical develops diagnostic instruments and reagents for bladder cancer and other reproductive tract tumors.
Zhigong Biomedical develops diagnostic technologies, instruments, and reagents, with a focus on bladder cancer testing. Its capabilities include nucleic acid diagnosis, biochemical diagnosis, and immunodiagnosis. Founded in 2021, the company is based in Yantai, China. It closed venture funding from Shandong Finance Investment Group in August 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in